Nu Skin Enterprises (NUS) Liabilities and Shareholders Equity (2009 - 2026)

Nu Skin Enterprises has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $1.4 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 1.05% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 billion (down 6.29% YoY) and the FY2025 annual result came in at $1.4 billion, down 4.33% from the prior year.
• Liabilities and Shareholders Equity eased to $1.4 billion in Q1 2026 per NUS's latest filing, from $1.4 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $1.9 billion in Q2 2022 and troughed at $1.4 billion in Q1 2026.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity advanced 1.7% in 2023, then decreased 20.12% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $1.8 billion in 2022, then declined by 0.68% to $1.8 billion in 2023, then slipped by 18.78% to $1.5 billion in 2024, then declined by 4.33% to $1.4 billion in 2025, then decreased by 2.03% to $1.4 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.4 billion, $1.4 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.